Ann Kim, MD
Vascular Surgery · Cleveland, OHNPI 1952667578
Payments from drug & device makers
Across 45 payments — averaging $200.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- W. L. Gore & Associates, Inc.$1K
- Penumbra, Inc.$208
- Cook Medical LLC$138
- Davol Inc.$136
- Shockwave Medical, Inc$111
- plus $175 from 4 others
What the payments were for
- Grants$4,33348%
- Travel & lodging$8289%
- Food & beverage$3,37437%
- Education$4965%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 24 | $6,909 |
| W. L. Gore & Associates, Inc. | 11 | $1,353 |
| Penumbra, Inc. | 2 | $208 |
| Cook Medical LLC | 2 | $138 |
| Davol Inc. | 1 | $136 |
| Shockwave Medical, Inc | 1 | $111 |
| Silk Road Medical, Inc. | 1 | $100 |
| Terumo Medical Corporation | 1 | $46 |
| AbbVie | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$4,494
- HawkOne$1,054
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$533
- ENDURANT IIS$463
- GORE TAG Conformable Thoracic Endoprosthesis$305
- GORE TAG Thoracic Branch Endoprosthesis$178
- GORE VIABAHN VBX Balloon Expandable Endo$157
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$151
- PHASIX$136
- Cook$125
- IN.PACT Admiral$120
- RUBY Coil$112
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$111
How this compares
$9,031 in reported general payments places this provider in the 65th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 18 | $35 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Cleveland
- Sean LydenCleveland$1.2M
- Francis CaputoCleveland$609K
- Levester KirkseyCleveland$433K
- Jae ChoCleveland$426K
- Matthew EagletonCleveland$390K
- Federico ParodiCleveland$81K
- Jon QuatromoniCleveland$63K
- Benjamin ColvardCleveland$38K
- Ravi AmbaniCleveland$32K
- Anthony RizzoCleveland$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.